Literature DB >> 21748453

Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.

Valentina Carubelli1, Marco Metra, Carlo Lombardi, Luca Bettari, Silvia Bugatti, Valentina Lazzarini, Livio Dei Cas.   

Abstract

Renal dysfunction is often present and/or worsens in patients with heart failure and this is associated with increased costs of care, complications and mortality. The cardiorenal syndrome can be defined as the presence or development of renal dysfunction in patients with heart failure. Its mechanisms are likely related to low cardiac output, increased venous congestion and renal venous pressure, neurohormonal and inflammatory activation and local changes, such as adenosine release. Many drugs, including loop diuretics, may contribute to worsening renal function through the activation of some of these mechanisms. Renal damage is conventionally defined by the increase in creatinine and blood urea nitrogen blood levels. However, these changes may be not related with renal injury or prognosis. New biomarkers of renal injury seem promising but still need to be validated. Thus, despite the epidemiological evidence, we are still lacking of satisfactory tools to assess renal injury and function and its prognostic significance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21748453     DOI: 10.1007/s10741-011-9265-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  111 in total

1.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

Review 2.  Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

Authors:  Jan O Friedrich; Neill Adhikari; Margaret S Herridge; Joseph Beyene
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

3.  Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate.

Authors:  J Kyhse-Andersen; C Schmidt; G Nordin; B Andersson; P Nilsson-Ehle; V Lindström; A Grubb
Journal:  Clin Chem       Date:  1994-10       Impact factor: 8.327

4.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.

Authors:  Kevin Damman; Dirk J Van Veldhuisen; Gerjan Navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan A Voors; Hans L Hillege
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

5.  Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time.

Authors:  Andrea B Kramer; Mirjan M van Timmeren; Theo A Schuurs; Vishal S Vaidya; Joseph V Bonventre; Harry van Goor; Gerjan Navis
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-18

6.  Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

Authors:  James B Young; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Lilin She; Jie Lena Sun; Clyde W Yancy; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-01-15       Impact factor: 2.778

7.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

8.  Tubular kidney injury molecule-1 in protein-overload nephropathy.

Authors:  Mirjan M van Timmeren; Stephan J L Bakker; Vishal S Vaidya; Veronique Bailly; Theo A Schuurs; Jeffrey Damman; Coen A Stegeman; Joseph V Bonventre; Harry van Goor
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-07

9.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

10.  Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Authors:  Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

View more
  11 in total

Review 1.  Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.

Authors:  Roland E Schmieder; Veselin Mitrovic; Christian Hengstenberg
Journal:  Clin Res Cardiol       Date:  2015-03-19       Impact factor: 5.460

Review 2.  The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

Authors:  Filippos Triposkiadis; Randall C Starling; Harisios Boudoulas; Gregory Giamouzis; Javed Butler
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 3.  New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.

Authors:  Deepa M Gopal; Flora Sam
Journal:  J Cardiovasc Transl Res       Date:  2013-04-23       Impact factor: 4.132

4.  Use of cardiovascular drugs and risk of incident heart failure in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Martin J Holzmann; Jan Sundquist; Kristina Sundquist
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-15       Impact factor: 3.738

5.  Angiotensin II receptor blocker attenuates intrarenal renin-angiotensin-system and podocyte injury in rats with myocardial infarction.

Authors:  Zhu-zhi Wen; Mu-yan Cai; Zun Mai; Dong-mei Jin; Yang-xin Chen; Hui Huang; Deng-feng Geng; Jing-feng Wang
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

6.  New challenges of geriatric cardiology: from clinical to preclinical research.

Authors:  Marco Malavolta; Daniele Caraceni; Fabiola Olivieri; Roberto Antonicelli
Journal:  J Geriatr Cardiol       Date:  2017-04       Impact factor: 3.327

7.  Urinary cadmium levels predict mortality of patients with acute heart failure.

Authors:  Ching-Wei Hsu; Cheng-Hao Weng; Cheng-Chia Lee; Dan-Tzu Lin-Tan; Pao-Hsien Chu; Kuan-Hsing Chen; Tzung-Hai Yen; Wen-Hung Huang
Journal:  Ther Clin Risk Manag       Date:  2017-03-27       Impact factor: 2.423

Review 8.  Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach.

Authors:  Victor Sarli Issa; Lúcia Andrade; Edimar Alcides Bocchi
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

9.  Cardiorenal biomarkers in acute heart failure.

Authors:  Rajiv Choudhary; Dipika Gopal; Ben A Kipper; Alejandro De La Parra Landa; Hermineh Aramin; Elizabeth Lee; Saloni Shah; Alan S Maisel
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

Review 10.  Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health.

Authors:  Alice Ravera; Valentina Carubelli; Edoardo Sciatti; Ivano Bonadei; Elio Gorga; Dario Cani; Enrico Vizzardi; Marco Metra; Carlo Lombardi
Journal:  Nutrients       Date:  2016-06-14       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.